Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

3 Mar 2026 12:09

RNS Number : 1602V
Athelney Trust PLC
03 March 2026
 

 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 170.7p at 28 February 2026.

Fund Manager's comment for February 2026

The US economy slowed in the final quarter of 2025, expanding at an annualised rate of 1.4%, down from 4.4% in Q3. The moderation reflected softer consumer demand and weaker exports following a strong Q3. Goods spending slowed, although services activity remained resilient, while government spending declined due to the temporary federal shutdown. Encouragingly, business investment remained firm, particularly in intellectual property and technology, and the decline in residential investment eased. For 2025 as a whole, GDP grew 2.2%, a modest slowdown but still supportive of corporate earnings. The Federal Reserve held rates at 3.5%-3.75%, with policymakers divided on the timing of further easing.

The Euro area grew 0.3% in Q4, maintaining its steady pace. Spain led performance, while Germany and Italy recorded modest gains. Full-year growth improved to 1.5%. Inflation eased to 1.7% in January, with core pressures moderating. The ECB held rates steady and signalled a cautious, data-driven approach. Manufacturing returned to expansion, supporting a gradual stabilisation.

The UK economy grew 0.1% in Q4. Production rebounded, though services momentum remained limited and construction weakened. Full-year growth reached 1.3%. Inflation eased to 3.0%, and the Bank of England held rates at 3.75%, with a bias toward gradual easing. Overall, growth remains subdued but stabilising.

Global equities gained in February, with the MSCI World index gaining 0.64%, US Markets were lower with the S&P 500 falling 0.87% and the Nasdaq falling 3.38%, while UK equities outperformed, with the FTSE 100 up 6.72%, and Small Cap and AIM indices gaining 2.80% and 0.24% respectively.

Our portfolio performance was positively impacted by gains in UK small and mid-cap companies during February. The portfolio NAV increased 0.84% for the month, after all fees and expenses. During the month, we added to our holding in Impax Asset Management and trimmed 4Imprint Group.

Many portfolio companies reported results or trading updates during February. Rightmove delivered strong 2025 results with revenue up 9% and operating profit up 12%, supported by an expansion in Commercial, Mortgages and Rentals. EPS rose 15% and a £90m buyback was announced. Management guides to 8-10% revenue growth in 2026, with continued AI-led product development supporting long-term margins.

Money Supermarket reported modest top-line growth up 2% with EPS up 5% and a solid dividend. Growth in Money and Home Services offset car insurance headwinds and higher Pay-Per-Click costs. A £25m buyback was announced, with 2026 EBITDA expected broadly in line with consensus. RELX delivered another high-quality year with underlying revenue up 7%, adjusted EPS up 10%, strong cash conversion and £1.5bn in buybacks. The shift towards analytics and AI-enabled tools continues to drive durable growth.

Dunelm Group grew revenue 3.6% with resilient margins, though profit softened due to timing effects. Strong cash flow supported a 17p interim and 25p special dividend. NWF saw weaker H1 performance driven by Fuels, though Food and Feeds improved. Full-year expectations were unchanged. S&U Plc expanded receivables and lending volumes, with strong collections at Advantage and record activity at Aspen.

The largest contributors to performance during the month were PayPoint, AEW UK and LionTrust while Keystone, Money Supermarket and AJ Bell were the largest detractors from performance.

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

 https://flagshipinvestments.com.au

· ECP Emerging Growth (ASX code: ECP)

 https://ecpam.com/emerging

· Global Masters Fund Limited (ASX code: GFL)

 www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

 www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBDGDXCGGDGLX
Date   Source Headline
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company
5th Jun 20179:51 amRNSNet Asset Value(s)
8th May 20179:20 amRNSNet Asset Value(s)
5th Apr 20179:16 amRNSNet Asset Value(s)
31st Mar 201711:52 amRNSAGM Statement
6th Mar 20179:53 amRNSNet Asset Value(s)
24th Feb 20177:00 amRNSAnnual Financial Report
3rd Feb 201712:17 pmRNSNet Asset Value(s)
6th Jan 20178:54 amRNSNet Asset Value(s)
5th Dec 20169:13 amRNSNet Asset Value(s)
3rd Nov 20168:45 amRNSNet Asset Value(s)
4th Oct 20169:34 amRNSNet Asset Value(s)
21st Sep 20169:44 amRNSDirector/PDMR Shareholding
2nd Sep 201612:35 pmRNSNet Asset Value(s)
2nd Aug 20168:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.